Identification of a novel PCNT founder pathogenic variant in the Israeli Druze population

Majewski Osteodysplastic Primordial Dwarfism type II (MOPDII) is a form of dwarfism associated with severe microcephaly, characteristic skeletal findings, distinct dysmorphic features and increased risk for cerebral infarctions. The condition is caused by bi-allelic loss-of-function variants in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medical genetics 2020-02, Vol.63 (2), p.103643-103643, Article 103643
Hauptverfasser: Weiss, Karin, Ekhilevitch, Nina, Cohen, Lior, Bratman-Morag, Sharon, Bello, Rachel, Martinez, Ariel F., Hadid, Yarin, Shlush, Liran I., Kurolap, Alina, Paperna, Tamar, Mory, Adi, Baris, Hagit N., Muenke, Maximilian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Majewski Osteodysplastic Primordial Dwarfism type II (MOPDII) is a form of dwarfism associated with severe microcephaly, characteristic skeletal findings, distinct dysmorphic features and increased risk for cerebral infarctions. The condition is caused by bi-allelic loss-of-function variants in the gene PCNT. Here we describe the identification of a novel founder pathogenic variant c.3465-1G > A observed in carriers from multiple Druze villages in Northern Israel. RNA studies show that the variant results in activation of a cryptic splice site causing a coding frameshift. The study was triggered by the diagnosis of a single child with MOPDII and emphasizes the advantages of applying next generation sequencing technologies in community genetics and the importance of establishing population-specific sequencing databases.
ISSN:1769-7212
1878-0849
DOI:10.1016/j.ejmg.2019.03.007